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THE metabolism of 1: 2-benzanthracene in rats and mice was investigated
by Berenblum and Schoental (1943) who reported the excretion in the faeces
of a phenolic derivative identified as 4'-hydroxybenzanthracene by methylation
and spectroscopic comparison with known methoxybenzanthracenes. Recent
studies by the author (Harper, 1959a) confirmed this identification for the mouse
faecal metabolite but the spectral analyses were considered to be consistent with
the presence of an additional phenolic derivative. The latter compound did in
fact appear to be the major component of the initial phenolic fraction conjugated
with sulphuric acid in the bile. It was suggested, by analogy with other hydro-
carbons, that this may be the 2'-hydroxy derivative and theoretical considerations
(Harper, 1959b) led to the proposal that the formation of this metabolite would
be favoured in the rabbit. Samples of both 2'-hydroxy- and 2'-methoxybenzan-
thracene have now been made available through the kind generosities of Professor
Badger in Australia and Dr. Schoental in this country so that it has been possible
to test these proposals by experiment.
MATERIALS AND MIETHODS
The two rabbits used in this work were maintained on a green-free diet for
two weeks prior to injection in order to reduce the chlorophyll content of the
gut and faeces.
Purified 1: 2-benzanthracene was prepared for injection either as a colloid
in distilled water (1 mg. per c.c.) or as a supersaturated solution in warm
tricaprylin (20 mg. per c.c.).
In the first experiment (Experimnent A) one rabbit was injected intraperi-
toneally with 10 c.c. of the tricaprylin solution and the faeces were collected
daily for a period of one week. Extraction into xylene via acetone was carried
out immediately and the phenolic metabolite was isolated from the pooled
xylenes as described previously (Harper, 1959a).
In the second experiment (Experiment B) the remaining rabbit was injected
intravenously via the ear vein with 20 c.c. of colloidal hydrocarbon and killed
at 2 hours. No fluorescence attributable to the hydrocarbon or its metabolites
was discernible within the tissues and the combined gall bladder and small
intestine were therefore homogenised and subjected to hot acid hydrolysis (1 N
hydrochloric acid at 100° C. for 1 hour under nitrogen). Extraction with xylene
then removed a blue-fluorescent derivative which was isolated by the procedure
referred to above for the faecal metabolite.METABOLISM OF BENZANTHRACENE IN THE RABBIT
RESULTS
Experiment A
A solution of the metabolite in ethanol possessed a bright blue fluorescence
which changed immediately to yellow on addition of sodium hydroxide.
Absorption spectroscopy in hexane revealed the presence of absorbing impurity
in the shorter wave length region but above 280 m,t the bands recorded (Fig. 1,
Table I) were, with one exception (see DISCUSSION), almost identical with those
of synthetic 2'-hydroxybenzanthracene.
TABLE I
Absorption bands in hexane (my)
Rabbit Mouse Methylated
faecal metabolite rabbit
metabolite 2'-OH BA-OH metabolite 2'-OMe
- . 226-227 . 226 . 226-227 . 227
- . [255-256] . 253 . [254-256] . [254-256]
- . 262 . [262] . 262-263 . 262-263
269-270 [270-272] 270 . 269
. [278-280] . [278-280] . 278-280 . 280
286 . 286 . 286 . 287 . 287
297 . 297 . 297 . 297 . 297*5
322-324 325-5 . [320-324] . 324-326 . 326-327
337 - . 337 . . -
341 . [340-341] . 338-342 . 340-342
354 . 354 . 354-355 . 354 . 354.5
373 . 373 . 372 . 372 . 372
394 . 394 . 394 . 393 . 393
2'-OH = 2'-hydroxybenzanthracene.
2'-OMe = 2'-methoxybenzanthracene.
BA-OH = free phenolic component of the mouse sulphate conjugate.
Methylation of the metabolite with dimethyl sulphate and excess sodium
hydroxide yielded a neutral derivative, purified by chromatography on alumina
from benzene followed by alumina from cyclohexane. The absorption spectrum
of this compound proved to be almost identical with that of 2'-methoxybenzan-
thracene (Fig. 2, Table I) and the phenolic derivative excreted in the faeces was
therefore concluded to be 2'-hydroxybenzanthracene.
Also included for comparison in the above data (Fig. 1, Table I) is the
absorption spectrum ofthe phenolic fraction obtained from the sulphate conjugate
of mouse bile (Harper, 1959a). This again is very similar to that of the 2'-
hydroxy derivative but differs from it in the sharpness of the major band at
286 m,u. In this respect it is similar to 4'-hydroxybenzanthracene and a probable
explanation of this behaviour is that a mixture of the 2'- and 4'-hydroxy
compounds is present, with the former in excess.
Experiment B
The primary aim of this experiment, to isolate conjugated metabolites from
the gall bladder and small intestine, was prevented by the large amount of acidic
colouring matter present in these organs. Recourse was had therefore to the
hydrolytic procedure described under MATERIALS AND METHODS in the hope
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FIG. 1.-Absorption spectra in hexane.
1. Phenolic component of the mouse sulphate conjugate (b ordinates).
2. 2'-Hydroxy-1: 2-benzanthracene (b ordinates).
3A and 3B.-Weak and concentrated solutions of the phenolic metabolite of benzanthra-
cene from rabbit faeces (3A-a ordinates; 3B-b ordinates).
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FIG. 2.-Absorption spectra in hexane.
1. 2'-Methoxy-1: 2-benzanthracene (b ordinates).
2. Methylated phenolic metabolite of benzanthracene from rabbit faeces (a ordinates).
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that a phenolic derivative liberated by this means from a sulphate conjugate
would be more amenable to isolation and purification. In this respect the
experiment was a success and the phenolic fraction thus obtained, although
impure, possessed absorption bands identical with those of the faecal metabolite.
DISCUSSION
Although there can be little doubt that the rabbit metabolite isolated in this
work is 2'-hydroxy-benzanthracene it is perhaps surprising, in view of the close
correspondence existing between other bands, that the rather diffuse 341 m/z
band of the synthetic compound should appear at 337 m,t in the metabolite.
This divergence, however, is undoubtedly due to the presence of absorbing
impurity for, as absorption in a mixture is additive, the superimposed effect of
decreasing background absorption upon a broad, almost horizontal maximum of
this nature will be to decrease absorption in the band passing from shorter to
longer wave lengths. The overall effect therefore will be a sharpening and
hypsochromic displacement of the maximum. Significantly, this effect was not
observed with the purer methylated form of the metabolite.
The isolation of free 2'-hydroxybenzanthracene from the gall bladder and
small intestine following acid hydrolysis is consistent with the presence in these
organs of a sulphate conjugate, if not perhaps the glucuronide, of the phenol.
The situation in respect therefore is probably similar to that occurring inthe mouse
but differs from it in the fact that hydroxylation occurs exclusively in the 2'-
position. The metabolism of 1: 2-benzanthracene in the mouse is indeed
analogous to that of 3: 4-benzpyrene for, although hydroxylation occurs at more
than one point of the molecule, the quantitative relationship existing between
the resultant products appears to be time dependent. Thus the initial major
products yielded by these two hydrocarbons in vivo are probably 2'-hydroxy-
benzanthracene and the unidentified F1 metabolite of 3: 4-benzpyrene but at
later time intervals these are replaced by the structurally analogous 4'-hydroxy-
benzanthracene and 8-hydroxybenzpyrene. It would appear therefore that the
initial products of hydroxylation in the mouse are themselves inhibitors of their
own synthesis and herein may lie the secret both of species differences in the site
of hydroxylation and in the graded carcinogenic response elicited by the
hydrocarbons in these species.
In conclusion it can be said that the hydroxylation of 1: 2-benzanthracene
in the 2'-position and the lack of carcinogenic activity in the rabbit is consistent
with the proposal advanced previously (Harper, 1959b) that an ortho form of
binding is favoured during hydroxylation in the microsomes of this species. The
carcinogenic action of this hydrocarbon in the mouse is then to be envisaged as a
secondary effect arising from an initial "poisoning " of the defensive ortho-
mechanism which then allows the active para form to come into play. Similar
considerations may also apply in the case of 1: 2: 5: 6-dibenzanthracene (without
activity in the rabbit) and 3: 4-benzpyrene (reduced activity in the rabbit).
Data of carcinogenic activity are taken from Hartwell (1951).
SUMMARY
1. 1: 2-Benzanthracene has been found to undergo hydroxylation in the
2'-position after intraperitoneal and intravenous injection in the rabbit. The.
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phenolic metabolite, 2'-hydroxybenzanthracene, is excreted in the faeces although
it is probably eliminated initially via the bile in conjugated form.
2. Previous data obtained on the metabolism of 1: 2-benzanthracene in
mice have been re-examined and are consistent with the view that hydroxylation
occurs in both the 2'- and 4'-positions with the former predominating during the
initial stages of metabolism.
3. These results are discussed in relation to former proposals concerning
hydroxylation and carcinogenesis.
I am greatly indebted to Dr. R. Schoental for her gift of 2'-methoxybenz-
anthracene and to Professor G. M. Badger for his gift of 2'- hydroxybenz-
anthracene.
The expenses ofthis work were defrayed from a block grant by the British
Empire Cancer Campaign.
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